πŸ‡ΊπŸ‡Έ FDA
Patent

US 10392412

Platinum anticancer agents

granted A61KA61K33/243A61P

Quick answer

US patent 10392412 (Platinum anticancer agents) held by The Regents of the University of California expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K33/243, A61P, A61P35/04